842 related articles for article (PubMed ID: 12676739)
21. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
[TBL] [Abstract][Full Text] [Related]
22. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB
J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
[TBL] [Abstract][Full Text] [Related]
23. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
[TBL] [Abstract][Full Text] [Related]
24. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
[TBL] [Abstract][Full Text] [Related]
25. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
27. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II.
Miller JA; Thai K; Scholey JW
Kidney Int; 1999 Dec; 56(6):2173-80. PubMed ID: 10594793
[TBL] [Abstract][Full Text] [Related]
29. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
Minutolo R; Andreucci M; Balletta MM; Russo D
Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
[TBL] [Abstract][Full Text] [Related]
30. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
[TBL] [Abstract][Full Text] [Related]
31. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
[TBL] [Abstract][Full Text] [Related]
32. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
Motwani JG; Fenwick MK; Morton JJ; Struthers AD
Circulation; 1992 Aug; 86(2):439-45. PubMed ID: 1638713
[TBL] [Abstract][Full Text] [Related]
33. Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs.
Golbaekdal K; Nielsen CB; Djurhuus JC; Pedersen EB
Transplantation; 1994 Dec; 58(11):1153-7. PubMed ID: 7992354
[TBL] [Abstract][Full Text] [Related]
34. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
35. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
Garcia R; Bonhomme MC; Diebold S
J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
Dickstein K; Gottlieb S; Fleck E; Kostis J; Levine B; DeKock M; LeJemtel T
J Hypertens Suppl; 1994 Jul; 12(2):S31-5. PubMed ID: 7965263
[TBL] [Abstract][Full Text] [Related]
37. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
Udelson JE; Bilsker M; Hauptman PJ; Sequeira R; Thomas I; O'Brien T; Zimmer C; Orlandi C; Konstam MA
J Card Fail; 2011 Dec; 17(12):973-81. PubMed ID: 22123358
[TBL] [Abstract][Full Text] [Related]
38. A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men.
Ilson BE; Boike SC; Martin DE; Freed MI; Zariffa N; Jorkasky DK
Clin Pharmacol Ther; 1998 Apr; 63(4):471-81. PubMed ID: 9585802
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
40. The effects of losartan on renal function in the newborn rabbit.
Prevot A; Mosig D; Guignard JP
Pediatr Res; 2002 Jun; 51(6):728-32. PubMed ID: 12032268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
